Bioactivx is a Singapore deep-tech spin-off from A*STAR and SingHealth developing synthetic, animal-free biomaterials for wound care and regenerative medicine. Its flagship product, Bioactiv Matrix, is a skin substitute designed to speed tissue regeneration and control inflammation without the cold-chain storage or sterile conditions animal-derived grafts require, making it viable in hospitals as well as military, emergency-response and remote-care settings. The company has submitted a regulatory data package in Singapore with a launch targeted there in late 2026, followed by FDA and EU filings as it expands across the region.
1
Round
1
Industry
5
Tags
Aug 26, 2026
Latest raise
Funding activity · 1 round
Aug 26, 2026
$3M
Seed
Led by Cocoon Capital
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
